ABOUT ASTRAZENECA
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.
SITE DESCRIPTION - Munich, Germany
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. SITE DESCRIPTION - Munich, Germany At Computational Pathology Munich (CPM), we make a significant contribution to high-performance, data-driven research and development. Our team operates in a demanding, fast-paced environment where excellent collaboration, clear communication and precise organization are critical. BUSINESS AREA AstraZeneca’s Enterprise AI organization is building the future of drug development by connecting data, technology, and expertise to accelerate breakthroughs across our portfolio. Within Computational Pathology and Biomarkers, we develop AI-powered solutions to advance patient selection, biomarker development, and clinical decision-making at scale. We work collaboratively across the organization to translate innovation into tangible impact across BioPharma, including CVRM, Respiratory & Immunology, and Rare Diseases. Do you thrive at the intersection of AI, biology, and clinical translation? We are looking for a Senior Scientist (m/f/d), Computational Pathology Biomarker Lead (BioPharmaceuticals) to drive the development of AI-enabled computational pathology and multimodal biomarkers that directly impact patient selection and drug development across our BioPharma portfolio. This role is based at our Munich, Germany office. In this role, you will collaborate with cross-functional teams to generate data-driven insights that inform clinical decisions across therapeutic areas such as cardiovascular, renal, metabolic, and respiratory diseases. You will contribute to innovative programs spanning small molecules and biologics, from early discovery through to late-stage development and lifecycle management.